• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特殊促消退介质能否带来最初期望从鱼油中获得的益处?

Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

作者信息

Rosenthal Martin D, Patel Jayshil, Staton Kyle, Martindale Robert G, Moore Frederick A, Upchurch Gilbert R

机构信息

Department of Surgery, Division of Trauma and Acute Care Surgery, University of Florida College of Medicine, PO Box 10019, Gainesville, FL, 32610-0019, USA.

Department of Medicine, Division of Pulmonary Critical Care, Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Curr Gastroenterol Rep. 2018 Aug 4;20(9):40. doi: 10.1007/s11894-018-0647-4.

DOI:10.1007/s11894-018-0647-4
PMID:30078085
Abstract

PURPOSE OF THE REVIEW

Fish oil (FO) supplementation has historically been used by individuals suffering from cardiovascular disease and other inflammatory processes. However, a meta-analysis of several large randomized control trials (RCTs) suggested FO conferred no benefit in reducing cardiovascular risk. Skeptics surmised that the lack of benefit was related to FO dose or drug interactions; therefore, the widely accepted practice of FO consumption was brought into question.

RECENT FINDINGS

Thereafter, Serhan et al. identified specialized pro-resolving mediators (SPMs) to be one of the bioactive components and mechanisms of action of FO. SPMs are thought to enhance resolution of inflammation, as opposed to classic anti-inflammatory agents which inhibit inflammatory pathways. Numerous diseases, including persistent Inflammation, immunosuppression, and catabolic syndrome (PICS), are rooted in a burden of chronic inflammation. SPMs are gaining traction as potential therapeutic agents used to resolve inflammation in cardiovascular disorders, inflammatory bowel disease, sepsis, pancreatitis, and acute respiratory distress syndrome (ARDS). This narrative reviews the history of FO and the various studies that made the health benefits of FO inconclusive, as well as an overview of SPMs and their use in specific disease states.

摘要

综述目的

鱼油(FO)补充剂历来被患有心血管疾病和其他炎症性疾病的人使用。然而,对几项大型随机对照试验(RCT)的荟萃分析表明,鱼油在降低心血管风险方面并无益处。怀疑者推测,缺乏益处与鱼油剂量或药物相互作用有关;因此,广泛接受的食用鱼油的做法受到了质疑。

最新发现

此后,塞尔汗等人确定了专门的促解决介质(SPM)是鱼油的生物活性成分和作用机制之一。与抑制炎症途径的经典抗炎药不同,SPM被认为可增强炎症的消退。许多疾病,包括持续性炎症、免疫抑制和分解代谢综合征(PICS),都源于慢性炎症负担。SPM作为用于解决心血管疾病、炎症性肠病、败血症、胰腺炎和急性呼吸窘迫综合征(ARDS)中炎症的潜在治疗剂正越来越受到关注。本叙述性综述回顾了鱼油的历史以及使鱼油对健康有益性结论不确定的各种研究,以及SPM的概述及其在特定疾病状态中的应用。

相似文献

1
Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?特殊促消退介质能否带来最初期望从鱼油中获得的益处?
Curr Gastroenterol Rep. 2018 Aug 4;20(9):40. doi: 10.1007/s11894-018-0647-4.
2
Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.类风湿关节炎患者的非处方鱼油补充剂和促分解代谢及促炎脂质介质。
Prostaglandins Leukot Essent Fatty Acids. 2023 Mar;190:102542. doi: 10.1016/j.plefa.2023.102542. Epub 2023 Jan 26.
3
Specialized pro-resolving mediators in respiratory diseases.呼吸系统疾病中的特异性促解决介质。
Curr Opin Clin Nutr Metab Care. 2022 Mar 1;25(2):67-74. doi: 10.1097/MCO.0000000000000805.
4
Specialized pro-resolving mediators in cardiovascular diseases.心血管疾病中的特异性促解决介质。
Mol Aspects Med. 2017 Dec;58:65-71. doi: 10.1016/j.mam.2017.02.003. Epub 2017 Feb 28.
5
Fish Oil Contaminated with Persistent Organic Pollutants Reduces Antioxidant Capacity and Induces Oxidative Stress without Affecting Its Capacity to Lower Lipid Concentrations and Systemic Inflammation in Rats.受持久性有机污染物污染的鱼油会降低大鼠的抗氧化能力并引发氧化应激,而不影响其降低血脂浓度和全身炎症的能力。
J Nutr. 2015 May;145(5):939-44. doi: 10.3945/jn.114.206607. Epub 2015 Mar 18.
6
Omega-3 long chain fatty acids and their metabolites in pregnancy outcomes for the modulation of maternal inflammatory- associated causes of preterm delivery, chorioamnionitis and preeclampsia.ω-3长链脂肪酸及其代谢产物在妊娠结局中的作用,用于调节与母体炎症相关的早产、绒毛膜羊膜炎和子痫前期的病因。
F1000Res. 2024 Dec 23;13:882. doi: 10.12688/f1000research.153569.2. eCollection 2024.
7
Bioactive products formed in humans from fish oils.人体中由鱼油形成的生物活性产物。
J Lipid Res. 2015 Sep;56(9):1808-20. doi: 10.1194/jlr.M060392. Epub 2015 Jul 15.
8
From Inflammation to Resolution: Specialized Pro-resolving Mediators in Posttraumatic Osteoarthritis.从炎症到解决:创伤后骨关节炎中的特异性促解决介质。
Curr Osteoporos Rep. 2023 Dec;21(6):758-770. doi: 10.1007/s11914-023-00817-3. Epub 2023 Aug 24.
9
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.利用特异性促解决脂质介质来避免 SARS-COV-2 患者的细胞因子风暴。
Biochem Pharmacol. 2023 Mar;209:115437. doi: 10.1016/j.bcp.2023.115437. Epub 2023 Jan 30.
10
Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.特异性促解决脂质介质:多发性硬化症的新兴治疗候选药物。
Clin Rev Allergy Immunol. 2021 Apr;60(2):147-163. doi: 10.1007/s12016-020-08796-4.

引用本文的文献

1
From Fish Oil to Resolution: A Narrative Review on the Potential of SPM-Enriched Marine Oil for Exercise-Induced Muscle Damage Recovery.从鱼油到消退:关于富含消退素的海洋油对运动诱导的肌肉损伤恢复潜力的叙述性综述
Nutrients. 2025 Jun 16;17(12):2014. doi: 10.3390/nu17122014.
2
Inflammatory Response and Anti-Inflammatory Treatment in Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS).持续性炎症-免疫抑制-分解代谢综合征(PICS)中的炎症反应与抗炎治疗
J Inflamm Res. 2025 Feb 14;18:2267-2281. doi: 10.2147/JIR.S504694. eCollection 2025.
3
Unraveling the Omega-3 Puzzle: Navigating Challenges and Innovations for Bone Health and Healthy Aging.

本文引用的文献

1
Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology.鉴定和结构解析促炎消退介质为炎症消退药理学提供了新的研究方向。
Br J Pharmacol. 2019 Apr;176(8):1024-1037. doi: 10.1111/bph.14336. Epub 2018 Jun 3.
2
Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis.证据表明,脓毒症后发生慢性危重症的患者存在持续免疫抑制。
Shock. 2018 Mar;49(3):249-258. doi: 10.1097/SHK.0000000000000981.
3
The Epidemiology of Chronic Critical Illness After Severe Traumatic Injury at Two Level-One Trauma Centers.
解开 Omega-3 的谜题:探索骨骼健康和健康老龄化的挑战与创新。
Mar Drugs. 2024 Sep 28;22(10):446. doi: 10.3390/md22100446.
4
Interventions for Pancreatitis-New Approaches, Knowledge Gaps, and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.胰腺炎干预措施——新方法、知识空白和研究机会:美国国立糖尿病、消化和肾脏疾病研究所研讨会总结。
Pancreas. 2024 Apr 1;53(4):e368-e377. doi: 10.1097/MPA.0000000000002333. Epub 2024 Mar 13.
5
Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities.持续炎症、免疫抑制和分解代谢综合征(PICS):定义、潜在治疗方法和研究重点的综述。
Br J Anaesth. 2024 Mar;132(3):507-518. doi: 10.1016/j.bja.2023.11.052. Epub 2024 Jan 4.
6
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.二十二碳六烯酸衍生的促解决脂质介质的潜在临床应用
Nutrients. 2023 Jul 26;15(15):3317. doi: 10.3390/nu15153317.
7
The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later.10 年后仍存在的炎症、免疫抑制和分解代谢综合征。
J Trauma Acute Care Surg. 2023 Nov 1;95(5):790-799. doi: 10.1097/TA.0000000000004087. Epub 2023 Aug 8.
8
Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.持续性炎症、免疫抑制和分解代谢综合征中的高分解代谢与抗分解代谢疗法
Front Nutr. 2022 Jul 13;9:941097. doi: 10.3389/fnut.2022.941097. eCollection 2022.
9
Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.解析 D1 通过 miR-30e-5p 改善系统性红斑狼疮中的 Treg/Th17 失衡。
Front Immunol. 2021 May 19;12:668760. doi: 10.3389/fimmu.2021.668760. eCollection 2021.
10
Chronic Critical Illness and PICS Nutritional Strategies.慢性危重病与危重症后综合征营养策略
J Clin Med. 2021 May 25;10(11):2294. doi: 10.3390/jcm10112294.
两家一级创伤中心严重创伤后慢性危重病的流行病学
Crit Care Med. 2017 Dec;45(12):1989-1996. doi: 10.1097/CCM.0000000000002697.
4
The novel lipid mediator PD1: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.新型脂质介质PD1:结构解析、合成、生物合成及生物活性概述
Prostaglandins Other Lipid Mediat. 2017 Nov;133:103-110. doi: 10.1016/j.prostaglandins.2017.06.003. Epub 2017 Jun 7.
5
Biosynthesis of proresolving lipid mediators by vascular cells and tissues.血管细胞和组织对促消退脂质介质的生物合成。
FASEB J. 2017 Aug;31(8):3393-3402. doi: 10.1096/fj.201700082R. Epub 2017 Apr 25.
6
Protectin D1 and resolvin D5 are effectors of intestinal protection.保护素 D1 和分辨率素 D5 是肠道保护的效应物。
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3963-3968. doi: 10.1073/pnas.1617290114. Epub 2017 Mar 29.
7
Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.特殊的促分解介质及其受体的结构阐明和生理功能。
Mol Aspects Med. 2017 Dec;58:114-129. doi: 10.1016/j.mam.2017.03.005. Epub 2017 Mar 31.
8
Persistent Inflammation, Immunosuppression and Catabolism Syndrome.持续性炎症、免疫抑制和分解代谢综合征
Crit Care Clin. 2017 Apr;33(2):245-258. doi: 10.1016/j.ccc.2016.12.001.
9
Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.发现专门的促解决介质标志着解决生理学和药理学的曙光的到来。
Mol Aspects Med. 2017 Dec;58:1-11. doi: 10.1016/j.mam.2017.03.001. Epub 2017 Mar 3.
10
Low salivary resolvin D1 to leukotriene B ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation.唾液中消退素D1与白三烯B的低比值可预测颈动脉内膜中层厚度:一种非消退性血管炎症的新型生物标志物。
Eur J Prev Cardiol. 2017 Jun;24(9):903-906. doi: 10.1177/2047487317694464. Epub 2017 Feb 14.